[Pemphigus vulgaris. Therapy with cyclophosphamide]

Area of Science:

• Immunodermatology
• Autoimmune diseases
• Blistering disorders

Background:

• Pemphigus vulgaris is a severe autoimmune blistering disease.
• Diagnosis relies on clinical, histological, and immunofluorescence findings.
• Optimal treatment strategies are not well-established.

Observation:

• The patient presented with pemphigus vulgaris.
• Multiple therapeutic attempts were made.
• Treatment efficacy and tolerance varied.

Findings:

• Systemic steroids combined with azathioprine, mycophenolate, or cyclophosphamide are common treatments.
• Limited data exists on the preferred first-line therapy.
• This case highlights the challenge of identifying effective and well-tolerated treatment.

Implications:

• Further research is needed to establish evidence-based treatment guidelines for pemphigus vulgaris.
• Personalized treatment approaches may be necessary.
• Improved therapeutic strategies can enhance patient outcomes and quality of life.